Back to search resultsSummaryRMgm-965
|
Successful modification | The parasite was generated by the genetic modification |
The mutant contains the following genetic modification(s) | Gene tagging |
Reference (PubMed-PMID number) |
Reference 1 (PMID number) : 24244852 |
MR4 number | |
top of page | |
Parent parasite used to introduce the genetic modification | |
Rodent Malaria Parasite | P. berghei |
Parent strain/line | P. berghei ANKA |
Name parent line/clone | P. berghei ANKA 2.34 |
Other information parent line | P. berghei ANKA 2.34 is a cloned, gametocyte producer line of the ANKA strain (PubMed: PMID: 15137943). |
top of page | |
The mutant parasite was generated by | |
Name PI/Researcher | B. Poulin; R. Tewari |
Name Group/Department | Centre for Genetics and Genomics |
Name Institute | School of Life Sciences, Queens Medical Centre, University of Nottingham |
City | Nottingham |
Country | UK |
top of page | |
Name of the mutant parasite | |
RMgm number | RMgm-965 |
Principal name | ISP1-GFP |
Alternative name | |
Standardized name | |
Is the mutant parasite cloned after genetic modification | Yes |
top of page | |
Phenotype | |
Asexual blood stage | ISP1-GFP expression |
Gametocyte/Gamete | ISP1-GFP expression |
Fertilization and ookinete | ISP1-GFP expression in ookinetes |
Oocyst | ISP1-GFP expression |
Sporozoite | ISP1-GFP expression |
Liver stage | ISP1-GFP expression |
Additional remarks phenotype | Mutant/mutation Phenotype ISP1-GFP was only detected at low levels by fluorescence microscopy in live asexual blood stages, and by IFA. ISP1-GFP showed faint cytosolic fluorescence in activatedmale and female gametocytes, and in addition there was strong peripheral membrane localisation in activated male gametocytes and a strong peripheral and polarised localisation in activated female gametocytes. In zygotes, this polarised area expanded to a crescent shape and the ISP1-GFP signal was reduced in the parasite cytosol. In contrast, ISP3-GFP was clearly evident in schizonts and merozoites, while in female gametocytes and zygotes it showed a pattern similar to ISP1-GFP with both a diffuse and localised distribution. The localisation of ISP3-GFP in developing schizonts resembles an IMC-like pattern. A striking difference between ISP1-GFP and ISP3-GFP was observed in ookinetes: while ISP1-GFP localisation was strong and largely limited to the apical tip of the ookinete, ISP3-GFP was distributed along the parasite periphery. Similarly, sporozoites isolated from mid-gut oocysts showed strong ISP1-GFP fluorescence at their apical tip, while ISP3-GFP was distributed throughout the cell but concentrated at the periphery of the parasite. Intriguingly, in sporozoites isolated from mosquito salivary glands, the distinctive apical localisation of ISP1-GFP was lost and instead the protein was distributed throughout the cell and concentrated at the periphery of the sporozoite, reminiscent of ISP3-GFP. While ISP1-GFP and ISP3-GFP fluorescence was distributed continuously along the length of extracellular sporozoites, it was disrupted at 5 h post-infection in the central protruding region of transforming intracellular sporozoites. At later stages of liver stage development (24 and 48 h), ISP1-GFP and ISP3-GFP appeared to be restricted to a small area at the parasite periphery.ISP1-GFP and ISP3- GFP expression increased towards the end of liver stage development, where both proteins were localised in internal structures inside the parasite. Liver merozoites released in culture appeared to display a circumferential distribution of ISP1 and ISP3. Evidence is presented that in the absence of ISP3, the apical localisation and polarity of ISP1 (PBANKA_120940) is altered. Other mutants |
top of page | |||||||||||||||||||||||||||
Details of the target gene | |||||||||||||||||||||||||||
Gene Model of Rodent Parasite | PBANKA_1209400 | ||||||||||||||||||||||||||
Gene Model P. falciparum ortholog | PF3D7_1011000 | ||||||||||||||||||||||||||
Gene product | inner membrane complex sub-compartment protein 1 | ||||||||||||||||||||||||||
Gene product: Alternative name | ISP1 | ||||||||||||||||||||||||||
top of page | |||||||||||||||||||||||||||
Details of the genetic modification | |||||||||||||||||||||||||||
Name of the tag | GFP | ||||||||||||||||||||||||||
Details of tagging | C-terminal | ||||||||||||||||||||||||||
Additional remarks: tagging | |||||||||||||||||||||||||||
Commercial source of tag-antibodies | |||||||||||||||||||||||||||
Type of plasmid/construct | Plasmid single cross-over | ||||||||||||||||||||||||||
PlasmoGEM (Sanger) construct/vector used | No | ||||||||||||||||||||||||||
Modified PlasmoGEM construct/vector used | No | ||||||||||||||||||||||||||
Plasmid/construct map | |||||||||||||||||||||||||||
Plasmid/construct sequence | |||||||||||||||||||||||||||
Restriction sites to linearize plasmid | |||||||||||||||||||||||||||
Selectable marker used to select the mutant parasite | hdhfr | ||||||||||||||||||||||||||
Promoter of the selectable marker | pbdhfr | ||||||||||||||||||||||||||
Selection (positive) procedure | pyrimethamine | ||||||||||||||||||||||||||
Selection (negative) procedure | No | ||||||||||||||||||||||||||
Additional remarks genetic modification | |||||||||||||||||||||||||||
Additional remarks selection procedure | |||||||||||||||||||||||||||
| |||||||||||||||||||||||||||
top of page |